CNCR vs. ROBO

Last updated Jun 24, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and ROBO (ROBO Global Robotics & Automation Index ETF) are both exchange-traded funds - CNCR is a Health & Biotech Equities fund tracking the Loncar Cancer Immunotherapy Index, while ROBO is a Robotics fund tracking the ROBO Global Robotics and Automation TR Index. Both are passively managed. CNCR charges 0.79%/yr vs 0.95%/yr for ROBO.

Performance

CNCR vs. ROBO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and ROBO Global Robotics & Automation Index ETF (ROBO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

ROBO

• 1D: -4.44%
• 1M: -5.15%
• YTD: 19.46%
• 6M: 18.99%
• 1Y: 46.62%
• 3Y*: 13.90%
• 5Y*: 5.19%
• 10Y*: 13.13%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. ROBO - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
ROBO ROBO Global Robotics & Automation Index ETF	15.67%

CNCR vs. ROBO - Sectors Allocation Comparison

Sectors	CNCR	ROBO
Healthcare	96.6%	4.6%
Financial Services	3.3%	1.9%
Basic Materials	-	-
Communication Services	-	1.4%
Consumer Cyclical	-	3.1%
Consumer Defensive	-	1.3%
Energy	-	-
Industrials	-	45.3%
Real Estate	-	-
Technology	-	43.6%
Utilities	-	-

Return for Risk

CNCR vs. ROBO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

ROBO

ROBO Risk / Return Rank: 56
ROBO Sharpe Ratio Rank: 58
ROBO Sortino Ratio Rank: 53
ROBO Omega Ratio Rank: 53
ROBO Calmar Ratio Rank: 57
ROBO Martin Ratio Rank: 59

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. ROBO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and ROBO Global Robotics & Automation Index ETF (ROBO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CNCR	ROBO	Difference
Sharpe ratio: Return per unit of total volatility	—	1.87	—
Sortino ratio: Return per unit of downside risk	—	2.47	—
Omega ratio: Gain probability vs. loss probability	—	1.32	—
Calmar ratio: Return relative to maximum drawdown	—	2.70	—
Martin ratio: Return relative to average drawdown	—	10.10	—

Drawdowns

CNCR vs. ROBO - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum ROBO drawdown of -43.65%. Use the drawdown chart below to compare losses from any high point for CNCR and ROBO.

Drawdown Indicators

	CNCR	ROBO	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-43.65%	+43.65%
Max Drawdown (1Y) Largest decline over 1 year	—	-17.35%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-27.92%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-43.65%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-43.65%	—
Current Drawdown Current decline from peak	0.00%	-8.35%	+8.35%
Average Drawdown Average peak-to-trough decline	0.00%	-12.90%	+12.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	4.63%	—

Volatility

Volatility by Period

	CNCR	ROBO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	11.64%	—
Volatility (6M) Calculated over the trailing 6-month period	—	20.52%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	25.07%	-25.07%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	24.06%	-24.06%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	23.31%	-23.31%

CNCR vs. ROBO - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is lower than ROBO's 0.95% expense ratio.

Dividends

CNCR vs. ROBO - Dividend Comparison

CNCR has not paid dividends to shareholders, while ROBO's dividend yield for the trailing twelve months is around 0.35%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROBO ROBO Global Robotics & Automation Index ETF	0.35%	0.42%	0.55%	0.05%	0.00%	0.18%	0.20%	0.37%	0.37%	0.02%	0.19%	0.28%

Frequently Asked Questions

Which ETF is better, CNCR or ROBO?

On fees, CNCR is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or ROBO?

CNCR is cheaper with a 0.79% expense ratio, compared with 0.95% for ROBO.

Which ETF pays a higher dividend yield, CNCR or ROBO?

ROBO has the higher dividend yield at 0.35%, compared with 0.00% for CNCR.

What is the main difference between CNCR and ROBO?

CNCR is categorized as Health & Biotech Equities, while ROBO is Robotics. CNCR tracks Loncar Cancer Immunotherapy Index, while ROBO tracks ROBO Global Robotics and Automation TR Index. Their fees differ too: 0.79% for CNCR and 0.95% for ROBO.